feed,title,long_url,short_url
Benzinga,FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant,https://benzinga.com/general/biotech/22/03/26316320/fda-says-current-dose-of-gsk-virs-covid-19-therapy-unlikely-to-work-against-omicron-subvariant,https://bit.ly/3uwdkk8
Benzinga,Tantech Wins Vehicle Order From Ecuador Customer,https://benzinga.com/news/22/03/26323815/tantech-wins-vehicle-order-from-ecuador-customer,https://bit.ly/3tLq8nr
